Survival analysis results revealed that colorectal cancer patients with low DDX3 protein expression exhibited poor overall survival (OS) (P = 7.95 × 10−6) and recurrence-free survival (RFS) (P = 1.33 × 10−6) (Figure 1A). Here, DDX3X is linked to colorectal cancer.